PCR And Realtime PCR Testing Global Market Like to Reach $27.78 Billion at a CAGR of 6.0% By 2028 | Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Cepheid Inc., Illumina Inc.

The pcr and realtime pcr testing market size has grown strongly in recent years. It will grow from $20.86 billion in 2023 to $22.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to disease diagnosis, research and genomic studies, automation and high throughput, pharmaceutical and biotechnology applications, point-of-care testing.

The pcr and realtime pcr testing market size is expected to see strong growth in the next few years. It will grow to $27.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to pandemic response, precision medicine, cancer diagnostics, infectious disease surveillance. Major trends in the forecast period include infectious disease testing, point-of-care testing, digital pcr, multiplex assays.

Market Overview -
Polymerase chain reaction (PCR) and Real-time Polymerase chain reaction (PCR) tests are used to detect and measure the DNA (or RNA) in a sample. These tests are conducted in automated thermal cyclers less sensitive to cross-contamination. It finds applications in cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2841&type=smp

Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And Realtime Pcr Testing Market
Early detection plays a key role in treating COVID-19 patients. The real-time RT-PCR technique is a susceptible and specific testing method that can deliver a reliable diagnosis in as fast as three hours, unlike the other laboratory tests that take an average of 6 to 8 hours. Real-time RT-PCR is significantly faster and has a lower potential for contamination or errors as the entire process is within a closed tube. Therefore, currently, it is considered to be the most accurate method available for the detection of coronavirus. This has created a huge demand for the growth of PCR testing market kits.

Competitive Landscape -
Major companies operating in the pcr and realtime pcr testing market include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.

New Test Kits And Systems Drive Growth In The Pcr And Real-Time Pcr Testing Market
The companies in the PCR and real-time PCR Testing market are coming up with new test kits and systems for the diagnosis of diseases. In January 2022, BioGenex Life Sciences Pvt Ltd created an RT-PCR kit for diagnosing COVID-19. This kit is capable of identifying COVID-19 resulting from various SARS CoV-2 strains, including the ""OmicronON"" without the need for RNA extraction and does so twice as fast as conventional PCR tests. Most companies are coming up with Real-time RT-PCR tests for the coronavirus, contributing to the growth of the PCR and Realtime PCR Testing market.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report

Key Segments -
The pcr and realtime pcr testing market covered in this report is segmented -
1) By Product: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Quantitative PCR, Digital PCR
3) By Application: Clinical Diagnostics, Life Science Research, Industrial Applications, Other Applications
4) By End-Use: Academic And Research Institutes, Pharmaceutical And Biotechnology, Clinical Diagnostics Labs And Hospitals, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.